This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Kan Lin
Introduction
Kan Lin is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of medicine, particularly in the treatment of kidney diseases. His innovative approach has led to the development of a unique application of a JAK inhibitor, which has the potential to change the landscape of kidney disease treatment.
Latest Patents
Kan Lin holds a patent for the "Application of JAK inhibitor in kidney disease." This patent outlines the use of a JAK inhibitor in the preparation of a drug aimed at treating or preventing kidney disease. With 1 patent to his name, Lin's work is a testament to his dedication to advancing medical science.
Career Highlights
Kan Lin is currently employed at Jiangsu Hengrui Pharmaceuticals Co., Ltd., a leading pharmaceutical company in China. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
One of his notable coworkers is Lu Su, with whom he has likely shared insights and expertise in their respective fields. Their collaboration may have played a role in the successful development of innovative treatments.
Conclusion
Kan Lin's contributions to the field of kidney disease treatment through his patent on JAK inhibitors highlight his role as an influential inventor. His work at Jiangsu Hengrui Pharmaceuticals Co., Ltd. continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile